First Episode Psychosis clinical trials

Explore recruiting first episode psychosis clinical trials.

Recruiting first episode psychosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

First Episode Psychosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AugmENtation witH cAnnabidiol iN first episode psyChosis: a doublE blind randomised controlled trial (STEP-ENHANCE Trial)

Netherlands, Greece, Germany, Italy, Austria, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial

France

Therapeutic use (Phase IV) EU CTIS Study details

Open-label, Multicenter, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Aripiprazole vs Paliperidone/Risperidone Using Multi-omics Data in Patients With a First Episode Psychosis

Spain

Therapeutic use (Phase IV) EU CTIS Study details

HAMLETT; Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

AMEND - Add-on MEmaNtine to Dopamine modulation to improve negative symptoms at first psychosis

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

First Episode Psychosis trials by city

First Episode Psychosis in Toronto First Episode Psychosis in Vancouver First Episode Psychosis in Montreal First Episode Psychosis in Calgary First Episode Psychosis in Edmonton First Episode Psychosis in Ottawa First Episode Psychosis in Winnipeg First Episode Psychosis in Quebec City First Episode Psychosis in Hamilton First Episode Psychosis in Kitchener First Episode Psychosis in London First Episode Psychosis in Halifax First Episode Psychosis in New York First Episode Psychosis in Los Angeles First Episode Psychosis in Chicago First Episode Psychosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease